Pharma Bio World - June 2014

Bu konuda

Competition in the global pharmaceutical and biotech industries are driven by scientific knowledge rather than manufacturing know-how. Intellectual Property (IP) is a pharmaceutical or biotech company’s most valuable resource, and its protection is a key to that company’s future success. With the generics industry consolidating and becoming more aggressive, the role of IP has become more important than ever.

The June issue of Pharma Bio World, themed on Intellectual Property, carries thought-provoking pieces on strategic importance of intellectual property to a pharmaceutical or biotech industries.

Pharma Bio World Magazine Description:

Pharma Bio World is a comprehensive business magazine that caters to the strategic information needs of senior professionals in the pharmaceutical and biotechnology industries, covering the best manufacturing and management practices, technological developments, new markets and cutting edge products and services. Through a well-defined combination of news analyses, snapshots of major happenings, and thoroughly researched features on best practices, quality, biotechnology, environment, markets, human resources, and so on, the magazine aims to provide well-rounded information on issues of strategic interest to practicing managers in the industry.